KYLE KENOBBIE: Open Payments
NPI 1316642234 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,968 in 81 payments from 34 companies in 2025. Trend: 2023 $910 · 2024 $1,973 · 2025 $1,968
Food & beverage: $1,968
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $244 |
| AstraZeneca Pharmaceuticals LP | 5 | $206 |
| Merck Sharp & Dohme LLC | 9 | $188 |
| Novartis Pharmaceuticals Corporation | 6 | $143 |
| Daiichi Sankyo Inc. | 5 | $124 |
| GENZYME CORPORATION | 4 | $109 |
| Eisai Inc. | 5 | $88 |
| BeOne Medicines USA, Inc. | 3 | $64 |
| PFIZER INC. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
Products named: LIBTAYO, KEYTRUDA, IMFINZI, Enhertu, Lenvima, TEVIMBRA, KISQALI, CARVYKTI.
Industry payments across GA — which companies pay providers there.
